GlassScriptPhysician profile
Kyle Matthew Kahlden
NPI 1497140875
$949.32
in general payments reported to CMS, 2019-2025
16 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.07 · 2020: $29.30 · 2022: $169 · 2023: $209 · 2024: $272 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $671.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $193.98 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $180.04 | 2022-2024 | Jornay Pm |
| Sobi, INC | $106.67 | 2019-2023 | |
| Cranial Technologies, INC | $105.36 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $55.21 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Alk-Abello, INC | $51.58 | 2025 | Neffy |
| Pfizer INC. | $40.93 | 2022-2024 | |
| Sanofi Pasteur INC. | $34.60 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $31.03 | 2025 | Jornay Pm |
| Cipher Pharmaceuticals US LLC | $26.93 | 2025 | Spinosad, Natroba |
| Ultragenyx Pharmaceutical INC. | $25.47 | 2024 | Crysvita |
| Ars Pharmaceuticals Operations, INC. | $24.82 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $23.64 | 2025 | Thinprep 2000 Processor |
| Neos Therapeutics, LP | $17.14 | 2019 | |
| Verrica Pharmaceuticals INC. | $16.58 | 2025 | Ycanth |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Kahlden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.